Gateway Investment Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Buy
24,915
+5,609
+29% +$322K 0.01% 357
2026
Q1
$1.17M Sell
19,306
-14,982
-44% -$873K 0.01% 315
2025
Q4
$1.85M Sell
34,288
-79,169
-70% -$3.81M 0.02% 304
2025
Q3
$5.12M Buy
113,457
+10,284
+10% +$480K 0.05% 197
2025
Q2
$4.78M Sell
103,173
-8,818
-8% -$433K 0.05% 198
2025
Q1
$6.83M Buy
111,991
+436
+0.4% +$25.4K 0.08% 160
2024
Q4
$6.31M Sell
111,555
-11
-0% -$615 0.07% 159
2024
Q3
$5.77M Buy
111,566
+240
+0.2% +$11.3K 0.06% 188
2024
Q2
$4.62M Buy
111,326
+13
+0% +$582 0.05% 203
2024
Q1
$6.04M Sell
111,313
-458,478
-80% -$23.4M 0.07% 193
2023
Q4
$29.2M Sell
569,791
-51,529
-8% -$2.7M 0.34% 77
2023
Q3
$36.1M Sell
621,320
-20,733
-3% -$1.27M 0.45% 55
2023
Q2
$41.1M Buy
642,053
+9,002
+1% +$604K 0.48% 52
2023
Q1
$43.9M Sell
633,051
-2,572
-0.4% -$181K 0.54% 53
2022
Q4
$45.7M Sell
635,623
-84,510
-12% -$6.37M 0.56% 45
2022
Q3
$51.2M Sell
720,133
-24,656
-3% -$1.79M 0.64% 37
2022
Q2
$57.3M Sell
744,789
-52,830
-7% -$4.02M 0.65% 37
2022
Q1
$58.3M Buy
797,619
+166
+0% +$11.1K 0.58% 40
2021
Q4
$49.7M Sell
797,453
-34,072
-4% -$2M 0.47% 55
2021
Q3
$49.2M Buy
831,525
+845
+0.1% +$55.6K 0.51% 54
2021
Q2
$55.5M Sell
830,680
-3,144
-0.4% -$205K 0.57% 48
2021
Q1
$52.6M Sell
833,824
-16,767
-2% -$1.04M 0.57% 48
2020
Q4
$52.8M Sell
850,591
-1,834
-0.2% -$113K 0.58% 43
2020
Q3
$51.4M Sell
852,425
-2,288
-0.3% -$138K 0.59% 45
2020
Q2
$50.3M Sell
854,713
-191,366
-18% -$11.4M 0.59% 44
2020
Q1
$58.3M Buy
1,046,079
+36,283
+4% +$2.22M 0.72% 38
2019
Q4
$64.8M Buy
1,009,796
+277,193
+38% +$15.9M 0.64% 39
2019
Q3
$37.1M Sell
732,603
-46,843
-6% -$2.2M 0.37% 73
2019
Q2
$35.3M Sell
779,446
-62,014
-7% -$2.89M 0.32% 79
2019
Q1
$40.1M Buy
841,460
+16,541
+2% +$824K 0.36% 76
2018
Q4
$42.9M Buy
824,919
+57
+0% +$3.06K 0.41% 70
2018
Q3
$51.2M Sell
824,862
-5,400
-0.7% -$320K 0.43% 65
2018
Q2
$45.9M Sell
830,262
-36,752
-4% -$1.98M 0.41% 68
2018
Q1
$54.8M Sell
867,014
-37,159
-4% -$2.39M 0.49% 57
2017
Q4
$55.4M Sell
904,173
-58,412
-6% -$3.65M 0.47% 58
2017
Q3
$61.4M Buy
962,585
+33,957
+4% +$1.98M 0.53% 50
2017
Q2
$51.7M Buy
928,628
+5,666
+0.6% +$308K 0.46% 62
2017
Q1
$50.2M Sell
922,962
-14,480
-2% -$794K 0.46% 62
2016
Q4
$54.8M Sell
937,442
-176,139
-16% -$9.63M 0.51% 54
2016
Q3
$60M Sell
1,113,581
-63,026
-5% -$4.05M 0.53% 53
2016
Q2
$86.5M Sell
1,176,607
-34,088
-3% -$2.41M 0.74% 39
2016
Q1
$77.3M Sell
1,210,695
-20,487
-2% -$1.29M 0.67% 43
2015
Q4
$84.7M Sell
1,231,182
-41,834
-3% -$2.76M 0.71% 39
2015
Q3
$75.4M Sell
1,273,016
-9,989
-0.8% -$634K 0.67% 41
2015
Q2
$85.4M Sell
1,283,005
-2,717
-0.2% -$179K 0.71% 38
2015
Q1
$82.9M Buy
1,285,722
+169
+0% +$10.6K 0.69% 40
2014
Q4
$75.9M Sell
1,285,553
-251,326
-16% -$14.2M 0.63% 46
2014
Q3
$78.7M Sell
1,536,879
-65,991
-4% -$3.3M 0.62% 43
2014
Q2
$77.8M Buy
1,602,870
+32,190
+2% +$1.59M 0.61% 47
2014
Q1
$81.6M Sell
1,570,680
-27,114
-2% -$1.44M 0.66% 42
2013
Q4
$84.9M Sell
1,597,794
-56,215
-3% -$2.86M 0.68% 41
2013
Q3
$76.5M Buy
1,654,009
+11,451
+0.7% +$503K 0.65% 43
2013
Q2
$73.4M Buy
+1,642,558
New +$71.3M 0.64% 44

Other funds holding BMY

Gateway Investment Advisers's BMY Position: Q2 2026 in Review

Gateway Investment Advisers increased its Bristol-Myers Squibb (BMY) stake by 29% in Q2 2026, buying an estimated $322K and bringing the position to 24,915 shares worth $1.44M. The position accounts for 0.01% of the portfolio, ranked #357.

Gateway Investment Advisers first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $86.5M in Q2 2016. 789 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Gateway Investment Advisers held 24,915 shares of Bristol-Myers Squibb worth $1.44M as of Q2 2026.
  • Gateway Investment Advisers bought 5,609 Bristol-Myers Squibb shares in Q2 2026, an estimated $322K.
  • Bristol-Myers Squibb made up 0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #357 holding.
  • Gateway Investment Advisers first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Gateway Investment Advisers's Bristol-Myers Squibb position peaked at $86.5M in Q2 2016.
  • 789 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.